Eiger BioPharmaceuticals Inc
OTC:EIGRQ

Watchlist Manager
Eiger BioPharmaceuticals Inc Logo
Eiger BioPharmaceuticals Inc
OTC:EIGRQ
Watchlist
Price: 8.5 USD
Market Cap: 12.6m USD

Wall Street
Price Targets

EIGRQ Price Targets Summary
Eiger BioPharmaceuticals Inc

There are no price targets for EIGRQ.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Eiger BioPharmaceuticals Inc Competitors:
Price Targets
VITR
Vitrolife AB
38% Upside
BBIO
BridgeBio Pharma Inc
12% Upside
ALKS
Alkermes Plc
57% Upside
ATX
Amplia Therapeutics Ltd
243% Upside
300685
Amoy Diagnostics Co Ltd
43% Upside
QURE
Uniqure NV
124% Upside
ACLX
Arcellx Inc
76% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
48% Upside

Revenue
Forecast

Revenue Estimate
Eiger BioPharmaceuticals Inc

The compound annual growth rate of Eiger BioPharmaceuticals Inc's revenue for the next 3 years is 31%.

N/A
Past Growth
31%
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Eiger BioPharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Eiger BioPharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EIGRQ's stock price target?
Not Available

EIGRQ doesn't have any price targets made by Wall Street professionals.

What is Eiger BioPharmaceuticals Inc's Revenue forecast?
Projected CAGR
31%

The compound annual growth rate of Eiger BioPharmaceuticals Inc's revenue for the next 3 years is 31%.

Back to Top